Riskpilot← Back to searchSign inGet full accessThermo Fisher Diagnostics AB
ABActiveOrg 5564013794UppsalaWholesale of pharmaceutical and medical goods · NACE 4646Est. 199026 employees
Revenue 2024
SEK 184M
-11% vs 2023
EBITDA margin
4.0%
-32% vs 2023
Equity ratio
74.0%
Financial strength
Net profit 2024
SEK 5,6M
-31% vs 2023
| Revenue | SEK 184M | -11% |
| EBITDA | SEK 7,4M | -32% |
| Net profit | SEK 5,6M | -31% |
| Total assets | SEK 72,3M | +17% |
| Equity | SEK 53,5M | +12% |
| Employees | 26 | — |
Legal name
Thermo Fisher Diagnostics AB
Org number
5564013794
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
4 juli 1990
Share capital
SEK 100 000
Employees
26 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva försäljning och marknadsföring av mikrobiologiska produkter och diagnostiska kit ävensom idka därmed förenlig verksamhet.
Address
Uppsala
Phone
+4686266050
Email
oxoid@oxoid.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 193 010 | 218 867 | 194 807 | 206 326 | 184 008 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 18 265 | 14 418 | 10 584 | 11 020 | 7 448 |
| Depreciation & amort. | −12 795 | −13 028 | −4 740 | −1 763 | −1 274 |
| EBIT | 5 470 | 1 390 | 5 844 | 9 257 | 6 174 |
| Net financials | −638 | −1 179 | −4 252 | 440 | 917 |
| Profit before tax | 4 831 | 212 | 1 591 | 9 696 | 7 091 |
| Tax | −1 192 | −43 | −749 | −1 601 | −1 516 |
| Net profit | 3 639 | 169 | 842 | 8 095 | 5 575 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 70 248 | 403 811 | 52 326 | 61 872 | 72 259 |
| Equity | 39 086 | 39 255 | 39 791 | 47 886 | 53 461 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 31 162 | 364 556 | 12 536 | 13 987 | 18 798 |
| Total debt | 31 162 | 364 556 | 12 536 | 13 987 | 18 798 |
EBITDA margin
4.0%
This company
15.8%
Market median
-75% vs market
20202024
Equity ratio
74.0%
This company
38.2%
Market median
+94% vs market
20202024
Return on equity
10.4%
This company
18.4%
Market median
+43% vs market
20202024
Net profit margin
3.0%
This company
8.1%
Market median
-63% vs market
20202024
Asset turnover
2.55×
This company
1.12×
Market median
+128% vs market
20202024
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LÅ Chief Executive Officer | Chief Executive Officer | 2022 |
LM Chief Auditor | Chief Auditor | 2023 |
| Former (1) | ||
LG Chief Auditor | Chief Auditor | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OXIOD INTERNATIONAL LTD
Thermo Fisher Diagnostics AB (this company)Board members of Thermo Fisher Diagnostics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Åsa Chatarina Lans | Chief Executive Officer | 0 companies |
| Lina Maria Josefine Jernebring | Chief Auditor | 0 companies |
| Lars Gustaf Kylberg | Chief Auditor | 0 companies |
| Lynn Gray | Board of Directors | 0 companies |
| Sara Maria Carrella | Board of Directors | 0 companies |
| Petrus Thomas Adrianus van der Zande | Chairman | 0 companies |